Greenlight Guru Announces The True Quality Virtual Summit

Greenlight Guru, the med-tech industry’s leading medical device quality management software (MDQMS) platform, today announced The Greenlight Guru True Quality Virtual Summit, a completely free and online summit providing attendees an opportunity to learn actionable tips, trends and best practices to achieve True Quality for their medical devices and business. The summit will take place on June 2-4, 2020. 

Quality is a vital component in every stage of the medical device lifecycle and Greenlight Guru is committed to supporting customers and the community of medical device professionals through these trying times. During the True Quality Virtual Summit, industry professionals will have an all-access pass to a three-day, three-track event providing actionable takeaways to help innovate faster, stay ahead of industry regulatory changes and use quality as their strategic advantage to grow their businesses.

“Our mission is to help improve the quality of life by helping device makers imagine, introduce and advance higher-quality devices faster, with less risk. The coronavirus has led to increased attention to medical devices worldwide, making it even more important that the industry gets things right the first time,” said Jon Speer, founder and VP of QA/RA at Greenlight Guru. “Hosting a virtual summit will allow us to safely offer a unique opportunity to bring together our customers, partners, employees and communities to find clarity in knowledge and expertise through an endless source of education, connections and inspiration.”

The three tracks focus on product development and executive leadership to regulatory compliance and generally helping those facing uncertainty and searching for clarity during the pandemic. More details are included below:

  • June 2, 2020: Track 1 – Go: What You Need to Know to Get New Devices to Market with Less Risk 

  • June 3, 2020: Track 2 – Grow: How to Advance the Success of Your Devices Already on the Market 

  • June 4, 2020: Track 3 – COVID-19: Practical Insights into Managing and Leading Medical Device Companies and Teams During the Pandemic 

The Greenlight Guru True Quality Virtual Summit is sponsored by various industry-leading organizations to help present the most rounded experience possible. Sponsors include AcKnowledge Regulatory Strategies, Alira Health, Azzur Group, EMERGO by UL, Galen Data, ICS, Kapstone Medical, KPMG, MedTech Innovator, Nelson Labs, Priority Designs, Proxima CRO, Rook Quality Systems, StarFish Medical, The RND Group, Two Harbors Consulting, Vascular Sciences, and Velentium

For more information or to get your free ticket to The Greenlight Guru True Quality Virtual Summit, visit: https://virtual-summit.greenlight.guru/

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version